References
- Parker S. L., Tong T., Bolden S., Wingo P. A. Cancer statistics, 1997. CA Cancer J. Clin. 1997; 47: 5–27
- Kopans D. B. The positive predictive value of mammography. AJR 1992; 158: 521–526
- Pollei S. R., Mettler F. A., Jr., Bartow S. A., Moradian G., Moskowitz M. Occult breast cancer: prevalence and radiographic detectability. Radiology 1987; 163: 459–462
- Taillefer R. The role of 99mtc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin. Nucl. Med. 1999; 29: 16–40
- Kao C. H., Wang S. J., Liu T. J. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur. J. Nucl. Med. 1994; 21: 432–436
- Amano S., Inoue T., Tomiyoshi K., Ando T., Endo K. In vivo comparison of PET and SPECT radiopharmaceuticals in detecting breast cancer. J. Nucl. Med. 1998; 39: 1424–1427
- Campeau R. J., Kronemer K. A., Sutherland C. M. Concordant uptake of Tc-99m sestamibi and Tl-201 in unsuspected breast tumor. Clin. Nucl. Med. 1992; 12: 936–937
- Mann B. D., Giuliano A. E., Bassett L. W., Barber M. S., Hallauer W., Morton D. L. Delayed diagnosis of breast cancer as a result of normal mammograms. Arch. Surg. 1983; 118: 23–24
- Moskowitz M. The predictive value of certain mammographic signs in screening for breast cancer. Cancer 1983; 51: 1007–1011
- Sickles E. A. Mammographic features of “early” breast cancer. AJR 1984; 143: 461–464
- Feig S. A. The role of ultrasound in a breast imaging center. Sem. US CT MR 1989; 10: 90–105
- Jackson V. P. The role of US in breast imaging. Radiology 1990; 177: 305–311
- Orel S. G., Schnall M. D., Powell C. M., Hochman M. G., Solin L. J., Fowble B. L., Torosian M. H., Rosato E. F. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995; 196: 115–122
- Weinreb J. C., Newstead G. MR imaging of the breast. Radiology 1995; 196: 593–610
- Waxman A. D. Thallium-201 in nuclear oncology. Nuclear Medicine Annual 1991, L. M. Freeman. Raven Press, New York 1991; 193–207
- Elgazzar A. H., Fernandes-Ulloa M., Silberstein E. B. Tl-201 as a tumour-localizing agent: current status and future considerations. Nucl. Med. Commun. 1993; 14: 96–103
- Sluyser M., Hoefnagel C. A. Breast carcinomas detected by thallium-201 scintigraphy. Cancer Lett. 1988; 40: 161–168
- Cimitan M., Volpe R., Candiani E., Gusso G., Ruffo R., Borsatti E., Massarut S., Rossi C., Morassut S., Carbone A. The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography. Eur. J. Nucl. Med. 1995; 22: 1110–1117
- Lee V. W., Sax E. J., McAneny D. B., Pollack S., Blanchard R. A., Beazley R. M., Kavanah M. T., Ward R. J. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J. Nucl. Med. 1993; 34: 2095–2100
- Maurer A. H., Caroline D. F., Jadali F. J., Manzone T. A., Maier W. P., Au F. C., Schnall S. F. Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy. J. Nucl. Med. 1995; 36: 1696–1700
- Alonso J. C., Soriano A., Zarca M. A., Guerra P., Alcazar R., Molino C. Breast cancer detection with sestamibi-Tc-99m and Tl-201 radionuclides in patients with non conclusive mammography. Anticancer Res. 1997; 17: 1661–1665
- Barr L., Cowan R., Nicolson M. Breast carcinoma. Churchill's Pocketbook of Oncology. Churchill Livingstone, New York 1997; 81–87